CYTOCHROME P450 3A13 AND ENDOTHELIN JOINTLY MEDIATE DUCTUS ARTERIOSUS CONSTRICTION TO OXYGEN IN MICE by Baragatti B et al.
doi:10.1152/ajpheart.00907.2010
 300:H892-H901, 2011. First published 30 December 2010;Am J Physiol Heart Circ Physiol
Aldo Paolicchi, Simona Nencioni and Flavio Coceani
Sodini, Stefano Luin, Gian Michele Ratto, Virginia Ottaviano, Eleonora Pagni, 
Barbara Baragatti, Enrica Ciofini, Francesca Scebba, Debora Angeloni, Daria
mice
mediate ductus arteriosus constriction to oxygen in 
-450 3A13 and endothelin jointlyPCytochrome 
You might find this additional info useful...
25 articles, 12 of which can be accessed free at:This article cites 
 http://ajpheart.physiology.org/content/300/3/H892.full.html#ref-list-1
including high resolution figures, can be found at:Updated information and services 
 http://ajpheart.physiology.org/content/300/3/H892.full.html
 can be found at:AJP - Heart and Circulatory Physiologyabout Additional material and information 
http://www.the-aps.org/publications/ajpheart
This infomation is current as of March 6, 2011.
 
ISSN: 0363-6135, ESSN: 1522-1539. Visit our website at http://www.the-aps.org/.
Physiological Society, 9650 Rockville Pike, Bethesda MD 20814-3991. Copyright © 2011 by the American Physiological Society. 
intact animal to the cellular, subcellular, and molecular levels. It is published 12 times a year (monthly) by the American
lymphatics, including experimental and theoretical studies of cardiovascular function at all levels of organization ranging from the 
 publishes original investigations on the physiology of the heart, blood vessels, andAJP - Heart and Circulatory Physiology
 o
n
 M
arch 6, 2011
ajpheart.physiology.org
D
ow
nloaded from
 
Cytochrome P-450 3A13 and endothelin jointly mediate ductus arteriosus
constriction to oxygen in mice
Barbara Baragatti,1,2* Enrica Ciofini,1* Francesca Scebba,1* Debora Angeloni,1,2* Daria Sodini,1
Stefano Luin,3 Gian Michele Ratto,4 Virginia Ottaviano,5 Eleonora Pagni,1 Aldo Paolicchi,5
Simona Nencioni,1 and Flavio Coceani1,2
1Scuola Superiore Sant’Anna and 2Institute of Clinical Physiology CNR, Pisa; 3Scuola Normale Superiore and 4Consiglio
Nazionale delle Ricerche, National Enterprise for nanoScience and nanoTechnology, Pisa; and 5Department of Experimental
Pathology, University of Pisa, Pisa, Italy
Submitted 13 September 2010; accepted in final form 22 December 2010
Baragatti B, Ciofini E, Scebba F, Angeloni D, Sodini D, Luin S,
Ratto GM, Ottaviano V, Pagni E, Paolicchi A, Nencioni S, Coce-
ani F. Cytochrome P-450 3A13 and endothelin jointly mediate ductus
arteriosus constriction to oxygen in mice. Am J Physiol Heart Circ
Physiol 300: H892–H901, 2011. First published December 30, 2010;
doi:10.1152/ajpheart.00907.2010.—The fetal ductus arteriosus (DA)
contracts to oxygen, and this feature, maturing through gestation, is
considered important for its closure at birth. We have previously
obtained evidence of the involvement of cytochrome P-450, possibly
of the 3A subfamily (CYP3A), in oxygen sensing and have also
identified endothelin (ET)-1 as the attendant effector for the contrac-
tion. Here, we examined comparatively wild-type (WT) and CYP3A-
null (Cyp3a/) mice for direct validation of this concept. We found
that the CYP3A subfamily is represented only by CYP3A13 in the
WT DA. CYP3A13 was also detected in the DA by immunofluores-
cence microscopy, being primarily colocalized with the endoplasmic
reticulum in both endothelial and muscle cells. However, a distinct
signal was also evident in the plasma membrane. Isolated DAs from
term WT animals developed a sustained contraction to oxygen with
transient contractions superimposed. Conversely, no tonic response
occurred in Cyp3a/ DAs, whereas the phasic response persisted
unabated. Oxygen did not contract the preterm WT DA but caused a
full-fledged contraction after retinoic acid (RA) treatment. RA also
promoted an oxygen contraction in the Cyp3a/ DA. However,
responses of RA-treated WT and Cyp3a/ mice differed in that only
the former abated with ET-1 suppression. This implies the existence
of an alternative target for RA responsible for the oxygen-induced
contraction in the absence of CYP3A13. In vivo, the DA was con-
stricted in WT and Cyp3a/ newborns, although with a tendency to
be less narrowed in the mutant. We conclude that oxygen acts
primarily through the complex CYP3A13 (sensor)/ET-1 (effector)
and, in an accessory way, directly onto ET-1. However, even in the
absence of CYP3A13, the DA may close postnatally thanks to the
contribution of ET-1 and the likely involvement of compensating
mechanism(s) identifiable with an alternative oxygen-sensing system
and/or the withdrawal of relaxing influence(s) operating prenatally.
oxygen sensing; development; retinoic acid; fetal and neonatal phys-
iology
THE DUCTUS ARTERIOSUS (DA) is a fetal shunt connecting the
pulmonary artery with the aorta and allowing blood to bypass
the unexpanded lungs. At birth, with the onset of lung venti-
lation and the attendant rise in blood oxygen tension (PO2), the
vessel constricts and eventually closes. The distinctive sensi-
tivity of DA muscle cells to oxygen is developmentally regu-
lated and matures more slowly compared with contractile
function (20). In fact, the preterm DA may contract little, or not
at all, to oxygen while presenting a fairly well-expressed
response to conventional spasmogens (1, 20, 27). Significantly,
retinoic acid (RA) promotes maturation of the susceptibility to
oxygen (27), and this action, although not yet defined in its
underlying mechanism, represents a useful tool for the study of
the oxygen-sensing system.
The identity of the DA oxygen sensor has been intensely
investigated through the years. We have previously assigned
this function to a cytochrome P-450 (CYP450) hemoprotein,
tentatively associated with the 3A subfamily (CYP3A), oper-
ating as a catalytic element in a monooxygenase reaction.
Supporting our scheme is the effectiveness of carbon monoxide
and a host of CYP450 inhibitors in curtailing the oxygen-
induced constriction (5). Coincidentally, we have found an
effector in endothelin (ET)-1, with the prime evidence being
the curtailment of the oxygen response upon ET-1 suppression
(7, 8) and the opposing action of oxygen (stimulation) versus
carbon monoxide (inhibition) on ET-1 release (5, 6).1 Intrinsic
in our scheme is also the idea that a hitherto-uncharacterized,
CYP3A-based monooxygenase product serves as the messen-
ger from the sensor to the effector. Another group (22) has
reached our same conclusion on the central role of ET-1 in the
DA constriction to oxygen. Alternatively, the sensing function
has been identified with a set of voltage-gated K (Kv) chan-
nels, Kv1.5 and Kv2.1, being inhibited by oxygen and causing
through the attendant depolarization an activation of voltage-
dependent L-type and T-type Ca2 channels (2, 12, 23). Even
the latter scheme, however, recognizes a contribution of ET-1
to the oxygen effect either as a key element in the activation
sequence (13) or as a reinforcing mechanism to Kv channel
operation (12). Here, we prove the mediator function of
CYP3A, specifically the mouse isoform CYP3A13, in DA
constriction to oxygen, and we also validate the concept of a
* B. Baragatti, E. Ciofini, F. Scebba, and D. Angeloni contributed equally to
this work.
Address for reprint requests and other correspondence: F. Coceani, Scuola
Superiore Sant’Anna, Piazza Martiri della Liberta` 33, Pisa 56127, Italy
(e-mail: coceani@sssup.it)
1 Our data are at variance with a report by Michelakis et al. (15) showing no
effect of oxygen on ET-1 formation in the DA. However, this result was
obtained in surgical specimens from infants as opposed, in our case, to DAs
from term fetal lambs being exposed for the first time to oxygen stimulation.
Basal values of ET-1 release were severalfold higher with the neonatal DA
and, while a methodological factor inherent to the species or the assay
procedure cannot be excluded, the difference may also be ascribed to the
special character of the vessel and intervening manipulations before surgery. In
the latter event, a distinct ET-1 rise due to oxygen might have been obscured
by a larger pool of the compound originating from nonrelevant sources.
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linkage of this hemoprotein with ET-1 in ensuring a full-
fledged response.
MATERIALS AND METHODS
Mice. Animals were housed in temperature- and humidity-con-
trolled quarters, with constant 12:12-h light-dark cycles, and were
given food and water ad libitum. Surgical procedures and experimen-
tal protocols were approved by the Animal Care Committee of the
Ministry of Health. We used CYP3A-null (Cyp3a/) mice of the FVB
strain (courtesy of Dr. A.H. Schinkel) (11) and verified the absence of
CYP3A13 by RT-PCR. C57BL/6 and FVB mice (Harlan, San Pietro al
Natisone, Italy) served as wild-type (WT) controls after confirming that
their DA responded similarly to oxygen.
Solutions and drugs. We used the following Krebs medium (in
mM): 118 NaCl, 4.7 KCl,1.0 KH2PO4, 0.9 MgSO4, 2.5 CaCl2, 11.1
dextrose, and 25 NaHCO3. Solutions were bubbled with gas mixtures
containing either no oxygen or oxygen in various concentrations
(2.5%, 12.5%, 30%, and 95%) plus 5% CO2 and balance nitrogen,
with the intent of duplicating the fetal (2.5% oxygen) and neonatal
(from 12.5% oxygen upward) conditions. Oxygen was required at
concentrations exceeding the physiological range for maximal con-
traction (8), likely as a consequence of its steep transmural gradient
even with a small-size vessel (10). We measured PO2 with a Chiron
gas analyzer (model 248, Halstead, UK) and found values of 7.31 
0.01/0.95  0.002, 16.6  0.07/2.16  0.009, 37.2  0.6/4.84 
0.08, 152  1/19.7  0.2, and 633  2/82.3  0.2 mmHg/kPa (pH
7.39  0.003) with 0%, 2.5%, 12.5%, 30%, and 95% oxygen mix-
tures, respectively.
We selected a synthetic peptide as an antigen to prepare a
polyclonal antibody against mouse CYP3A13 in the rabbit (custom
generated by Primm, Milano, Italy). This peptide (amino acids
325–336: NH2-PDVQKKLQDEID-COOH) was selected within
regions of maximal antigenicity in the CYP3A13 sequence (Gen-
Bank NP_031845), avoiding regions with potential posttransla-
tional modifications or with homology to other agents. We con-
firmed the specificity of the antibody by dot blot on a nitrocellulose
membrane (Hybond, Amersham, Buckinghamshire, UK) using the
antigenic peptide in increasing concentrations until saturation. The
signal was detected with a chemiluminescent substrate (Super Signal
West Pico, Thermoscientific, Waltham, MA) and recorded on Kodak
Biomax XAR film (Sigma, St. Louis, MO). Nevertheless, our anti-
body still elicited a faint immunostaining in the Cyp3a/ DA, and
this feature was shared by a commercial antibody (CR3310, Biotrend
Chemikalien, Cologne, Germany) reportedly selective for mouse
CYP3A11 and CYP3A13 (data not shown). Polyclonal ET-1 and
ET-converting enzyme (ECE)-1 antibodies were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA). We also used ET-1 (human/
porcine type, Peninsula, San Carlos, CA), the prostaglandin endoper-
oxide analog 9,11-epoxy-methano-15-hydroxy-prosta-5,13-
dienoic acid (U-44069; Cayman Chemical, Ann Arbor, MI), the
thromboxane A2 (TXA2) analog 9,11-epithio-11,12-methano-
TXA2 (ONO-11113, courtesy of ONO Pharmaceutical, Osaka,
Japan), retinoic acid (RA; all-trans-retinol palmitate; Sigma), and
the ET-1/ETA receptor antagonist BQ-123 (Calbiochem, San Diego,
CA). ET-1 was dissolved in sterile water with 0.05% human serum
albumin (100 M), and aliquots of this stock solution were stored at
20°C until use. U-44069 and ONO-11113 were dissolved in dis-
tilled ethanol (0.1 and 5 mg/ml, respectively), and aliquots (stored at
70°C) were diluted with saline and Tris buffer (pH 7.4), respec-
tively. RA was instead diluted in safflower seed oil.
In vitro recording. We carried out experiments in fetal mice, both
term and preterm (at 19 and 17 days gestation, respectively), that had
been delivered by Cesarean section under halothane anesthesia and
killed by cervical dislocation. Selected experiments were also per-
formed in the preterm animal whose mother had been treated with RA
(1 mg/kg, equivalent to 1,818 IU) by the intramuscular route for 3
consecutive days (4). The procedure for dissection of the ductus has
been described in detail (8). Briefly, we secured the animal with its
left side up in a chamber containing ice-cold Krebs solution gassed
with 5% CO2 in nitrogen. Through a thoracotomy, the ductus was
exposed and separated from the adjoining large blood vessels. Once
isolated, the vessel was suspended onto 25-m tungsten wires
(Cooner, Chatsworth, CA) and placed inside an organ bath. The fluid
was gassed with a mixture containing 2.5% oxygen, and the same gas
mixture was flushed through a hood covering the bath. Preparations
were then equilibrated (60 min at 37°C) under minimum stretch
(preterm/term: 0.05  0.001/0.09  0.003 mN/mm, n  26 and 43,
respectively), and the attendant internal circumference (C0), with the
related resting dimensions (see Supplemental Material, Supplemental
Table 1),2 served as a reference in selecting the appropriate load.
Afterward, tension was applied to attain an operating circumference
coinciding with the condition in vivo (C45, preterm/C50, term 0.36 
0.004/0.44 0.005 mN/mm). The actual experiment was started after
a second 60- to 120-min period of equilibration.
We used distinct protocols to test oxygen and ET-1. In protocol 1
(n  42), we assessed the capability of WT (C57BL/6 and FVB) and
Cyp3a/ DAs to contract to oxygen over a range of concentrations
(12.5%, 30%, and 95%). We carried out experiments in both preterm
and term preparations and in preterm preparations from RA-treated
animals. BQ-123 (1 M) was tested on some of these preparations.
We used a similar design with ET-1 in protocol 2 (n  27), limiting
the WT control to the C57BL/6 strain and avoiding any test with
BQ-123. ET-1 was tested in cumulative concentrations (0.1–300 nM)
using 3- to 10-fold increments. In either protocol, ONO-11113 (0.1
M) and, in some experiments, U-44069 (0.3 M) provided a
reference for maximal contraction. For analysis of responses, we
considered as baseline the net tension (i.e., total tension minus applied
2 Supplemental Material for this article is available at the American Journal
of Physiology-Heart and Circulatory Physiology website.
Fig. 1. Expression of cytochrome P-450 3A13 (CYP3A13) mRNA (A) and
endothelin (ET)-1 mRNA (B) in the ductus arteriosus (DA) of untreated
preterm and term mouse fetuses and preterm fetuses treated with retinoic acid
(RA) or its vehicle [safflower oil (So)]. The relative level by quantitative
RT-PCR is given against expression data from the untreated preterm DA
(value 1). Data are means SE; n 5 except for the vehicle control, where
n  3 and 4 in A and B, respectively). *P  0.027 relative to the vehicle
control (by ANOVA followed by the Bonferroni test).
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tension) developed by the preparation before any treatment. Effects of
constrictors were measured by the rise in tension over baseline and
were expressed in absolute values. Unless otherwise specified, exper-
iments were carried out at 2.5% O2.
Gene expression analysis. We pooled DA specimens from term and
preterm (without/with RA pretreatment) fetuses in distinct groups
(30–40 animals/group) according to the experimental condition. The
adult liver or kidney was used as reference, depending on the gene.
Total RNA was isolated (3) with Tripure isolation reagent (Roche,
Indianapolis, IN), and its yield was measured spectrophotometrically.
DNase I (Roche)-treated RNA was reverse transcribed with 1 unit of
thermoscript RT (Invitrogen, Carlsbad, CA) in the presence of
hexanucleotide primers. The cDNA product (0.1 or 0.2 g/group) was
used for amplification in semiquantitative and then comparative real-
time PCR for selected genes. Primer sequences were retrieved from
the literature or were designed on purpose for the former analysis (see
Supplemental Table 2), whereas the latter used an online library
(Applied Biosystems, Foster City, CA). For semiquantitative analysis,
electrophoresis of PCR products was performed on agarose gels [1.5%
(wt/vol)] stained with ethidium bromide, and bands from the DA and
a reference organ were visualized in parallel. Quantitative real-time
PCRs (40 cycles) were performed on an ABI Prism 7700 instrument
using TakMan Universal PCR mastermix (Applied Biosystems). We
quantified gene expression in triplicate by the comparative threshold
cycle method (ABI Prism Relative Quantification Software, Applied
Biosystems) using -actin as a reference.
Immunohistochemistry. We prepared serial, transversal sections (5
m thick) of frozen DAs in embedding medium (OCT, Sakura
Finetek, Torrance, CA). Sections were fixed in cold acetone (10 min
at 20°C) and, for antigen retrieval, were immersed in citrate buffer
(0.01 M, pH 6.0) for a 15-min treatment in a microwave oven. The
resulting specimens were kept in goat (CYP3A13, ECE-1) or chicken
(ET-1) serum [10% (vol/vol)] for 1 h at room temperature and were
subsequently incubated overnight with CYP3A13, ET-1, or ECE-1
antibody (dilution 1:50, 1:25, and 1:100, respectively) at 4°C. Goat
anti-rabbit lgG (CYP3A13, 1:250 and ECE-1, 1:50; Zymed, Carlsbad,
CA) or chicken anti-goat lgG (ET-1, 1:300; Santa Cruz), both conju-
gated to FITC, served as the secondary antibody. Specificity of
binding was verified by omitting the primary antibody. We deter-
mined the colocalization of immunoreactive sites with the plasma
membrane and endoplasmic reticulum using, respectively, the mark-
ers wheat germ agglutinin conjugates marine blue and BODIPY
558/568 Brefeldin A (Molecular Probes, Eugene, OR). Slides were
protected with an anti-fading agent (Vectashield, Vector, Burlingame,
CA), and images were acquired on a fluorescence (model DMR,
Leica) or confocal (TCS-SP2 on model DM IRE 2, Leica) micro-
scope. We confirmed the colocalization of signals in both the plasma
membrane and endoplasmic reticulum by building a three-dimen-
sional (3-D) picture from serial images through the z-axis (deconvo-
lution technique) (14). Voxel dimensions were chosen to satisfy the
Nyquist criterion based on the experimental point spread function, and
the point spread function was measured with 500-nm spherical beads
(TetraSpeck, Molecular Probes). No appreciable photobleaching was
noted during image acquisition. We used Huygens Professional
3.2.0p7 software (Scientific Volume Imaging, Hilversum, The Neth-
erlands) to calculate the Pearson coefficient documenting the presence
(value, 0 to 1) or absence (value, 0 to 1) of colocalization. The
Fig. 2. Immunofluorescence micrographs of the mouse DA. A–C: epifluorescence images of sections incubated with CYP3A13 antibody. A: preterm DA;
B: RA-treated preterm DA; C: term DA. D–F: confocal images of sections stained in sequence with CYP3A13 antibody (D), the endoplasmic reticulum marker
(E), and the two superimposed (F). et, Endothelium; smc, smooth muscle. Scale bars  50 m for A–C and 10 m for D–F.
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same software afforded an overlap colocalization map in the form of
isolocalization surfaces.
Cell culture and Ca2 imaging. We cultured DA muscle cells to
measure changes in the cytosolic Ca2 concentration ([Ca2]i) in
response to oxygen. Endothelium-denuded WT and Cyp3a/ term
vessels were prepared for this purpose using a procedure that has been
previously described and validated (3, 24). They were then placed in
5 ml of Dulbecco’s modified medium supplemented with 0.25 M
dextrose and 2 mg/ml collagenase (Clostridium histolyticum type I,
Sigma). After an incubation at 37°C for 30 min, the tissue suspension
was centrifuged (170 g, 5 min), and the resulting cell pellet was
resuspended in 1 ml of Dulbecco’s modified medium containing 10%
FBS and a combination of penicillin (100 U/ml) and streptomycin (0.1
mg/ml). Dispersed cells were then plated onto a 35/12-mm glass dish
(Willco Wells, Amsterdam, The Netherlands) and were incubated at
37°C. Medium was replaced after 24 h, and the operation was
repeated at 48-h intervals. Cells were studied after 3–8 days once they
had grown to a subconfluent monolayer. Their identity was confirmed
with an antibody against -actin (Sigma). We assessed changes in cell
Ca2 levels due to oxygen from the fluorescence signal ratio between
Ca2-sensitive fluo-4 AM (Invitrogen) and Ca2-insensitive 5-(and
6)-carboxy snarf-1 (SNARF; Invitrogen). SNARF was used to correct
for focus shifts and mechanical artefacts that may occur with pro-
longed recording. The recording solution had the following compo-
sition (in mM): 130 NaCl, 3.1 KCl, 2.0 CaCl2, 1.0 MgCl2, 5.0
dextrose, 1.0 K2HPO4, 4.0 NaHCO3, 10 HEPES/NaOH, 1.0 ascorbic
acid, 0.5 myoinositol, 2.0 pyruvic acid, and 0.02 ()-sulfinpyrazone
(pH 7.2–7.4). Before dye loading, cell-bearing dishes were washed
with warm, serum-free recording solution and were incubated for 20
min at 37°C. They were then placed in the loading medium, which
consisted of 10 M fluo-4 and 9 M SNARF in a pluronic acid
(20%)-DMSO (0.002%) mixture. Treatment (at 37°C) continued for
15 min, and after three washings, cells were returned to the recording
solution for a 30-min period. Afterward, cells were transferred to a
temperature-controlled (37°C), humidified chamber (PeCon, Erbach,
Germany) through which a preheated 2.5% O2-5% CO2-balance
nitrogen mixture was passed for baseline recording. This mixture was
replaced by 30% O2-5% CO2-balance nitrogen at the 40-min mark,
and responses of WT versus Cyp3a/ cells were examined compar-
atively. The oxygen concentration was selected from experiments in
the isolated vessel where it produces a near-maximal contraction (see
below). Imaging was performed at 30-s intervals on an inverted
confocal microscope (TCS-NT, Leica) equipped with a 	40 magni-
fication oil-immersion lens. Dye excitation was provided by a 488-nm
wavelength from an ArKr laser and was read in the fluorescein and
rhodamine spectral bands for fluo-4 and SNARF, respectively. A total
Fig. 3. Subcellular localization of CYP3A13 in the mouse DA. A: high-power colocalization (arrowhead) of CYP3A13 immunostaining with the endoplasmic
reticulum. B and C: colocalization of CYP3A13 immunostaining with the plasma membrane marker as evident from the deconvolution of z-stacks (close circle,
vessel lumen). B: image from xy scanning at a fixed value of z (horizontal and vertical lines are the intersections of the other two planes) with xz (bottom box)
and yz (right box) sections referring to the entire stack. C: three-dimensional maximum intensity projection-rendered image from deconvolved z-stacks shown
in B with isolocalization sites appearing in red. Arrowheads indicate corresponding regions in B and C with examples of colocalization. Note that Pearson
coefficient for the group was 0.095  0.014; n  5 [coefficient for the CYP3A-null (Cyp3a/) DA was 0.028  0.012, n  3; data not shown]. Scale bars  5
m for A and 10 m for B and C.
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of 30–90 cells (average: 50 cells) were studied in each experiment
using National Institutes of Health (NIH) ImageJ (Bethesda, MD)
software for image analysis and quantification.
In vivo experiments. We used term fetuses (19 days gestation)
delivered by Cesarean section under halothane anesthesia and new-
borns at 3 h after vaginal delivery. Fetuses were also obtained from
dams that had been made hyperoxic (3-h exposure to 100% O2) with
the intent of studying separately the effect of oxygen alone versus
birth (8). We assessed the DA caliber in fetuses (normoxic and
hyperoxic) and newborns, both WT and Cyp3a/, with the whole
body freezing technique (8). This technique provides a faithful image
of the condition in vivo, as verified by us in several experimental
models where the DA was either constricted or overdilatated. Briefly,
transversal sections (5 m thick), progressing serially through the
whole length of the frozen DA, were obtained and stained with 1%
methylene blue. We photographed each section with a charged-
coupled device solid-state camera (COHU, San Diego, CA) and
measured lumen area with the NIH ImageJ program. Both maximal
and minimal values were retrieved from each series for computation.
Statistical analysis. Data are presented as means  SE. We calcu-
lated P values with Student’s t-test or ANOVA followed by the
Bonferroni or Tukey tests. P values of 
0.05 were considered as
statistically significant.
RESULTS
Gene expression analysis. We detected only one CYP3A
isoform, CYP3A13, among the several members of this sub-
family (see Supplemental Table 2). The transcript was already
evident in the preterm DA, and, in fact, its expression abated
with advancing gestation (Fig. 1A). Likewise, a downward
trend relative to the vehicle control was seen upon RA treat-
ment (Fig. 1A). We also found ET-1, but, unlike CYP3A13, it
was not affected by gestational age or RA (Fig. 1B).
Localization of CYP3A13, ECE-1, and ET-1. Using fluores-
cence microscopy, we found CYP3A13 immunostaining in the
DA. Its distribution was diffuse, encompassing both intimal
and medial layers, and did not show any obvious change with
fetal age or RA treatment (Fig. 2, A–C). Furthermore, with the
appropriate markers, we proved that the signal mainly colocal-
ized with the endoplasmic reticulum (Figs. 2, D–F, and 3A).
This finding was confirmed with the deconvolution technique
and the demonstration of an appropriate value for the Pearson
coefficient (0.25  0.02, n  5; data not shown). Some
immunostaining was also located in the plasma membrane with
a spot-like pattern, and the actual coincidence of the signal
with this structure was verified in 3-D deconvoluted images
(Fig. 3, B and C). Equally diffuse was ECE-1 immunoreactiv-
ity, with its intensity remaining unchanged from preterm to
term (Fig. 4, A and C) but increasing instead in response to RA
(Fig. 4, A and B). Regardless of age, on the other hand, ET-1
was markedly expressed in the intimal layer and only moder-
ately in the medial layer. RA, however, enhanced the signal
within the media, thus making this immunostaining fairly
uniform across the vessel wall (Fig. 4, D–F). In all cases, we
did not detect any immunoreactivity in the absence of the
primary antibody.
Fig. 4. Immunofluorescence micrographs of the mouse DA. Sections incubated with ET-converting enzyme (ECE)-1 (A–C) and ET-1 (D–F) antibody. A and
D: preterm DA; B and E: RA-treated preterm DA; C and F: term DA. Scale bars  50 m.
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Isolated DA: contractile behaviour and response to oxygen
and ET-1. Dimensions of the WT DA were greater in term than
preterm animals and were consistent among strains (see Sup-
plemental Table 1). At term, the vessel developed a variable
degree of tension during equilibration (0.1  0.02 mN/mm)
with transient contractions of uneven amplitude (0.1–0.6 mN/
mm) and/or low-amplitude fast discharges often superimposed.
In contrast, the preterm DA presented barely any active tone
(0.05  0.02 mN/mm) and only occasionally was its baseline
record interrupted by a contractile event. The two age groups
also differed in their response to reference spasmogen (0.1 M
ONO-11113 or 0.3 M U-44069), with the contraction at term
being about twice as high as that before term (1.02  0.07 and
0.63  0.05 mN/mm, respectively). In agreement with a
previous report (8), we observed a concentration-dependent
contraction of the term DA to oxygen unfolding with episodes
of tonic and phasic activity (Figs. 5, A and B, and 6A). In
contrast, the preterm DA did not contract to oxygen or con-
tracted marginally only at the highest concentration (Fig. 5A).
In fact, oxygen caused occasionally a modest relaxation instead
of a contraction. Unlike oxygen, ET-1 had a similar effect in
preterm and term preparations (Fig. 7A). In both cases, there
was a progressively greater contraction from 0.1 to 10–100
nM, with a subsequent reversal beyond this range.
We found the Cyp3a/ DA to differ from its WT counter-
part in some respects. Its size tended to be smaller at term (see
Supplemental Table 1), and baseline tone was minimal or
absent altogether (0.02  0.01 mN/mm). Nevertheless, the
vessel still generated transient contractions, comparable in
pattern with those of the WT, and also responded normally
(term: 1.04  0.1 mN/mm), or in a slightly reduced fashion
(preterm: 0.37  0.03 mN/mm), to a TXA2 mimic. Equally
distinctive was its response to oxygen and ET-1. In the former
case, the tonic component was virtually abolished (Fig. 5B),
whereas transient contractions, whether slow (varying ampli-
tude) or fast (low amplitude), persisted and presented, in fact,
an acceleration through the test (Fig. 6B). ET-1, on the other
hand, produced a contraction both at term and before term, but
its response profile indicated lesser effectiveness (Fig. 7B).
RA promoted an oxygen response equally effectively in WT
and Cyp3a/ animals. As shown in Fig. 5A, the preterm WT
DA, which is normally unresponsive to oxygen, yielded after
treatment a full-fledged contraction, overlapping that of the
untreated term DA. Likewise, RA had an enabling effect on the
preterm Cyp3a/ DA, although with a certain degree of
variability over the entire oxygen range (Fig. 5B). In the WT
DA, the RA-induced oxygen response was reversed by the
ET-1 antagonist BQ-123 (1 M, n  4), and the residual
contraction straddled threshold or was even replaced by a
marginal relaxation (maximum: 0.16 mN/mm). Conversely,
the equivalent response in the Cyp3a/ DA was suppressed
by BQ-123 only in one of five experiments, whereas it devel-
Fig. 5. Oxygen-induced contraction in the mouse
DA: age and CYP3A dependence and activation
by RA. A: absence of the oxygen response in the
preterm DA and its appearance upon RA treat-
ment (n  5 or 6). No response was seen in the
untreated DA even when 95% oxygen was tested
first (data not shown). B: loss of the oxygen
response with CYP3A deletion and its reversal
by RA (n  5 or 6). Note that the residual
response in the Cyp3a/ vessel did not reach
significance relative to baseline at 2.5% oxygen.
WT, wild type. *P  0.002 vs. term or preterm
DA plus RA treatment (A); *P  0.014 vs. the
WT DA (B) (by ANOVA followed by the Bon-
ferroni test).
Fig. 6. Representative responses to oxygen in WT (A) versus Cyp3a/ (B) DAs from term fetal mice. Note the absence in the Cyp3a/ vessel of baseline tone
and sustained contraction to oxygen; only transient contractions showed an acceleration with the rise in oxygen tension (for details, see text).
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oped unabated in the remainder (maximal tension: 0.33  0.08
mN/mm, n  4). ET-1 action on the preterm DA was also
unevenly modified by RA depending on genotype. No change
was seen in the WT vessel (Fig. 7A), whereas the attenuated
response of Cyp3a/ increased to match that of the WT
(Fig. 7B).
Effect of oxygen on [Ca2]i in DA muscle cells. We recorded
a stable [Ca2]i baseline in DA muscle cells (both WT and
Cyp3a/) through exposure to 2.5% oxygen. Upon raising the
oxygen concentration to 30%, [Ca2]i of WT cells increased
steadily in time without reaching a plateau over a 60-min
period (Fig. 8). No immediate response occurred with
Cyp3a/ cells, and a smaller upward trend was also observed
with significance being reached only at the end of recording
(Fig. 8).
In vivo experiments. We found a widely patent DA in the
term fetus regardless of genotype (Fig. 9, A and B). Maternal
hyperoxia induced a modest constriction, not reaching signif-
icance in the WT fetus (Fig. 9A) and but becoming significant
in the Cyp3a/ fetus (Fig. 9B). As expected, the DA con-
stricted rapidly in the neonate, and at 3 h from delivery it was
almost closed in either WT strain (Fig. 10A). We observed a
comparable pattern in the Cyp3a/ newborn, although the
vessel tended to be less narrowed (Fig. 10A). In addition, in
any stage of the closing process, the inner lining of the
Cyp3a/ DA appeared smoother and showed less of the
intraluminal growth typical of the WT DA (Fig. 10B).
DISCUSSION
Our study proves that CYP3A13 is critical for the contrac-
tion of the isolated DA to oxygen, specifically for its sustained
component. This conclusion, which accords with a host of
earlier data (5), rests on three main findings: 1) loss of the tonic
contraction to oxygen upon deletion of CYP3A coupled with
the demonstration that CYP3A13 is the only member of this
particular subfamily of CYP450 hemoproteins in the DA; 2) a
reduced response to oxygen in DA muscle cells lacking
CYP3A; and 3) the occurrence of CYP3A13 in DA muscle
cells, with a distinct expression in the plasma membrane,
where it is best positioned to sense oxygen changes against a
steep transmural gradient (10). The role being proposed for
CYP3A13 is closely intertwined with that assigned earlier to
ET-1 since suppression of the latter, by pharmacological means
(7, 22) or deletion of the ETA receptor subtype (8), also results
in loss of the DA constriction to oxygen. Indeed, the impor-
tance of ET-1 is strengthened by our study insofar as the
peptide is implicated in the ability of RA to promote ex novo
an oxygen response in the preterm WT DA. We demonstrated,
in fact, a reversal of RA action by the ETA antagonist BQ-123
and, in a complementary fashion, an enhanced immunoreac-
tivity for ET-1 and its immediate synthetic enzyme ECE-1
upon RA treatment. However, outwardly incongruent with our
data in vitro is the finding that, when hyperoxia was elicited in
the mother, the Cyp3a/ DA constricted in utero similarly, or
even more, compared with the WT DA. Furthermore, the DA
closed almost normally in the Cyp3a/ newborn. Our discus-
sion will address this particular issue and, coincidentally, the
nature of the relationship between CYP3A13 and ET-1 in
mediating the contraction to oxygen.
Earlier on, we proposed a scheme with a CYP450 hemopro-
tein as an oxygen sensor and ET-1 as an effector, with a
hypothetical monooxygenase product being the messenger be-
tween the two. Our in vitro results, while giving an identity to
the postulated sensor, are in accord with this arrangement and,
furthermore, better qualify the role being played by ET-1. It is
interesting to note in this connection the reduced responsive-
Fig. 7. Effect of ET-1 on DAs from preterm
(both untreated and RA treated) and term
mouse fetuses. A: WT DAs (n  4–6).
B: Cyp3a/ DAs (n  4). *P 
 0.0001 vs.
untreated Cyp3a/ DAs, both preterm and
term (by ANOVA followed by the Bonferroni
test). Note the lesser response of Cyp3a/
compared with WT DAs in either age group
(P 0.009 and 0.004 at term and before term,
respectively).
Fig. 8. Effect of oxygen on cytosolic Ca2 in DA smooth muscle cells. WT
(C57BL/6 strain; ); Cyp3a/ (Œ). Cells were loaded with fluo-4 and SNARF
(see MATERIALS AND METHODS), and recordings were made for 20 min at 2.5%
oxygen before the switch (time 0) to 30% oxygen. Results are presented as the
ratio of fluo-4 to SNARF divided by the baseline value at time 0 (f/f)
Difference beween WT and Cyp3a/ curves: P 
 0.001 (by ANOVA; n 
3 for both). *P 0.01 vs. baseline ()/P 0.005 vs. baseline (Œ) (by ANOVA
followed by the Tukey test). Note that baseline recording at 2.5% oxygen did
not change with time in either cell type.
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ness to ET-1 in the Cyp3a/ DA, implying that this oxygen
effector is fully functional only with a viable sensor. However,
a better appreciation of the relative contribution of CYP3A13
and ET-1 to the oxygen contraction emerges from the analysis
of findings in their respective mutants. Significantly, we have
found that any phasic event in the response to oxygen remains
unchanged after CYP3A deletion, whereas ETA deletion re-
sults in the disappearance of both tonic and phasic components
(8). From this, we can assume that the oxygen action on DA
comprises two, mutually reinforcing, processes: a primary one
involving in sequence CYP3A13 and ET-1 and ensuring a
persistent rise in tone and an accessory one being exerted
directly onto ET-1 and manifesting itself as the transient
contractions over the baseline. Recognition of this dual modal-
ity for oxygen action has some consequences. It may account
for the apparent divergence of findings in vitro and in vivo.
Specifically, the occurrence of DA narrowing in the hyperoxic
Cyp3a/ fetus, which, based on our scheme, could be as-
cribed to a direct activation of the ET-1 system. ET-1 could, in
fact, produce this effect by itself and/or through a cascade of
events being triggered by the increased motility of the vessel
and the attendant disturbance in blood flow. Consistent with
this concept is the finding that the hyperoxic stimulus is
ineffective in the ETA-null (ETA/) fetus (8). In this context,
one should also stress the peculiarities of the situation in vivo,
particularly with a mutant, where overlapping or even latent
mechanisms may come into play to compensate for the loss
of the oxygen-sensing function. A relevant example is found
in the ETA/ newborn, where the DA closes normally
despite the absence of the oxygen-sensing mechanism (see
Fig. 10. Postnatal closure of DA in WT versus
Cyp3a/ mice. A: DA cross-sectional area
for WT (C57BL/6 and FVB strains) and
Cyp3a/ mice with each point applying to a
different fetus. B: representative sections of
WT and Cyp3a/ DAs obtained at the point
of maximal constriction. da, Ductus arteriosus;
ao, aorta; pa, pulmonary artery. Note the
smoother inner surface in Cyp3a/ compared
with WT DAs. Scale bars  150 m.
Fig. 9. Effect of maternal hyperoxia on the
DA of term fetal mice. A and B: maximal and
minimal DA cross-sectional areas for WT
(C57BL/6 strain; A) and Cyp3a/ (B) DAs
with each point representing a single exper-
iment. *P  0.032 vs. the corresponding
normoxic value (by Student’s t-test).
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Ref. 8). A compensating mechanism was identified at the time
in the withdrawal of relaxing influences responsible for DA
patency in utero (8), and the same explanation may now apply
to the Cyp3a/ newborn.
However well founded, our position on the role of
CYP3A13 must be considered vis-a`-vis another proposal as-
cribing sensing function to a distinct set of Kv channels (i.e.,
Kv1.5 and Kv2.1) amenable to inhibition by oxygen (12, 23).
Leaving aside the fact that oxygen changes may still affect
muscle tone in a K-treated vessel (25), which argues against
a unique role of K channels, we have already pointed out that
these two schemes are not mutually exclusive since ET-1 can
interfere with K channel function (8, 26). A similar unifying
position is also found in the work of Keck et al. (13), where
evidence is presented of an ET-1 step preceding K channel
blockade in the oxygen activation sequence. Our present re-
sults in RA-pretreated animals shed further light on this issue.
Specifically, we found that the RA-induced oxygen contraction
in the Cyp3a/ DA, unlike that in the WT DA, was most of
the time not inhibited by BQ-123. In our view, any such escape
from ET-1 inhibition attests to the operation of an alternative,
possibly K channel-mediated, oxygen-sensing mechanism
becoming prominent in response to CYP3A13 deletion. Of
relevance here is the likely presence in the promoter of oxygen-
sensitive Kv1.5 and Kv2.1 channels of recognition sites for a
transcription factor [RA receptor/retinoid X receptor 1 (DR1)]
being activated by RA (see http://www.genomatix.
de).3 Hence, RA could enhance both mechanisms being pro-
posed for oxygen sensing, but their relative importance would
change depending on the state of the vessel. How this potential
duality of oxygen effectors may impact on DA function re-
mains to be ascertained. However, it could well account for the
reported inconsistencies in the Cyp3a/ mutant between find-
ings in vitro and in vivo.
In principle, a therapeutic approach promoting oxygen con-
traction should be superior to the currently used inhibitors of
PGE2-induced relaxation in the management of prematurely
born infants with a persistent DA. Any interference with PGE2
is, in fact, amenable to compensation by alternative relaxing
mechanisms (3, 20, 21). Furthermore, PGE2 itself plays a role
not only in prenatal patency of the vessel but also in its clos-
ure postnatally (16, 18, 28, 29). A combination of these diverse
actions likely explains the high incidence of failures with the
treatment to date, which is based on cyclooxygenase inhibitors
such as indomethacin or ibuprofen (17, 19). A better knowl-
edge from our work of the oxygen activation sequence, and
specifically of the RA role therein, opens new therapeutic
prospects.
A final point, deserving a comment, relates to the abrupt
maturation of the oxygen-induced contraction vis-a`-vis the
concomitant downregulation of the CYP3A13 transcript. RA
also mimics this effect of age while promoting a full-fledged
oxygen contraction. Any explanation for these findings is
necessarily speculative. However, an appealing possibility is
that transcript changes reflect a maturation-linked restriction of
the alleged sensor to discrete regions in DA muscle, perhaps
pacemaker sites reportedly implicated in the initiation of the
oxygen contraction (9).
In conclusion, we have identified the main oxygen sensor in
DA with CYP3A13 and have shed light on the linkage of this
hemoprotein with ET-1 in sustaining the oxygen contraction.
We have also confirmed the effectiveness of RA in promoting
the oxygen action, and hence its maturation through gestation,
and have located in the ET-1 system, plus possibly the K
channel oxygen-sensing mechanism, the target for the agent.
These findings lend themselves to a clinical application, spe-
cifically in the development of better tools for the management
of premature infants with a persistent DA. In addition, they
may serve as a model for oxygen sensing elsewhere in the
body.
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